Women
Antiretroviral Trials
Currently Enrolling
Canadian HIV Women’s Sexual and Reproductive Health Cohort Study (CHIWOS)
Sponsor: CTN
Contact: Rosemarie Clarke
(416) 340-4800 ext. 6723
The ProSPAR Study: Progesterone Supplementation for HIV-positive Pregnant women on Anti-Retrovirals
Sponsor: CIHR, CANFAR
Contact: Rosemarie Clarke or Adri D’Aquila
(416)340-4800 ext. 6723 or (416)340-4800 ext. 8170
Not Enrolling, but Ongoing
A Phase IIIb, Randomized, Open-label Study of the Safety and Efficacy of Dolutegravir/Abacavir/Lamivudine Once Daily Compared to Atazanavir and Ritonavir Plus Tenofovir/Emtricitabine Once Daily in HIV-1 Infected Antiretroviral Therapy Naïve Women
(ARIA, ING117172)
Sponsor: ViiV Healthcare
Contact: Rosemarie Clarke
(416) 340-4800 ext. 6723
Study of an HPV VLP Vaccine in a Cohort of HIV Positive Girls and Women
Sponsor: University of California, Los Angeles, Merck, Case Western Reserve
Contact: Rosemarie Clarke
(416) 340-4800 ext. 6723 or
Adriana D’Aquila
(416) 340-4800 ext. 8170
